Schedule 13G ownership disclosure

VASCULAR BIOGENICS LTD

Security class unavailable · CUSIP: M96883109

Event date: 2019-08-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,623,570
Percent of class
4.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-19-037103
Form type
SC 13G/A
Filer
Pitango Venture Capital Fund IV, L.P.
CIK
CIK 1287224
Filed
Aug 01, 2019
Reporting period
Aug 01, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub